Physician profile
William Watterson
NPI 1578588976
$10,740.41
in general payments reported to CMS, 2019-2025
52 companies · $1,816 in 2025
The $1,816 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $682 · 2020: $1,169 · 2021: $1,814 · 2022: $1,865 · 2023: $1,701 · 2024: $1,693 · 2025: $1,816.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,210.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,686.17 | 2021-2025 | Qulipta, Vraylar, Ubrelvy |
| Astrazeneca Pharmaceuticals Lp | $1,280.20 | 2019-2025 | Farxiga, Tezspire, Airsupra |
| Lilly USA, LLC | $890.08 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Pfizer INC. | $633.92 | 2019-2025 | |
| Amgen INC. | $623.40 | 2019-2025 | Repatha, Otezla, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $545.88 | 2019-2025 | Xifaxan, Trulance |
| Novo Nordisk INC | $530.01 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amarin Pharma, INC. | $522.83 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $356.08 | 2019-2025 | Trintellix |
| Allergan, INC. | $275.54 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $265.07 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $244.98 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $209.70 | 2019-2025 | Ajovy |
| Lundbeck LLC | $200.18 | 2022-2025 | Rexulti, Vyepti |
| Esperion Therapeutics, INC. | $190.96 | 2020-2022 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $176.57 | 2023-2025 | Caplyta |
| Vanda Pharmaceuticals INC. | $175.17 | 2024-2025 | Fanapt, Hetlioz |
| Exact Sciences Corporation | $171.42 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $139.17 | 2019-2025 | Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $131.28 | 2019-2021 | |
| Upsher-Smith Laboratories LLC | $126.66 | 2020-2022 | |
| Corium, LLC | $113.54 | 2022-2023 | Azstarys |
| Qorumpartners | $112.49 | 2022 | |
| Idorsia Pharmaceuticals US INC | $102.59 | 2022-2024 | Quviviq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.76 | 2019-2025 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $67.33 | 2025 | Rexulti |
| Sanofi Pasteur INC. | $67.04 | 2019-2023 | |
| Eisai INC. | $66.51 | 2021-2022 | |
| Astellas Pharma US INC | $66.20 | 2023-2025 | Veozah |
| Janssen Pharmaceuticals, INC | $65.64 | 2019-2022 | |
| Coala Life INC | $58.87 | 2023 | Coala Heart Monitor |
| Axsome Therapeutics, INC. | $57.77 | 2022-2024 | Auvelity |
| Lumenis, INC | $53.24 | 2021 | |
| Alk-Abello, INC | $53.13 | 2023-2024 | Grastek, Odactra, Ragwitek |
| Ironshore Pharmaceuticals INC. | $51.98 | 2019-2024 | |
| Kowa Pharmaceuticals America, INC. | $33.20 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.10 | 2024-2025 | |
| Neos Therapeutics, Lp | $27.72 | 2020-2024 | Adzenys Xr-Odt |
| Ars Pharmaceuticals Operations, INC. | $25.24 | 2025 | Neffy |
| Adlon Therapeutics L.P. | $24.16 | 2019-2021 | |
| Becton, Dickinson and Company | $22.83 | 2025 | Bd Max System, Bd Max Instrument |
| Sumitomo Pharma America, INC. | $19.99 | 2024 | Gemtesa |
| Kaleo, INC. | $18.99 | 2021 | |
| Phadia US INC. | $18.80 | 2019 | |
| Inogen, INC. | $17.97 | 2021 | |
| Abbott Laboratories | $16.95 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $16.16 | 2024 | Opsumit, Uptravi |
| Mylan Specialty L.P. | $14.52 | 2022 | |
| Genentech USA, INC. | $13.79 | 2020 | |
| Amneal Pharmaceuticals LLC | $13.49 | 2025 | Unithroid |
| Concordia Pharmaceuticals INC. | $13.01 | 2019 | |
| Shire North American Group INC | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Watterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.